Scientific work
Publications.
Microbial therapeutics, host responses, and the biology between them.
Find me on Google Scholar2026
Frontiers in Immunology 17, 1925200
Saccharomyces boulardii reduces food intake and attenuates weight gain in diet-induced obese mice: links to gut microbial, metabolic, and immune remodeling
doi: 10.3389/fimmu.2026.1925200Gut Microbes 18 (1), 2690687
Multi-omics analysis of Saccharomyces boulardii supplementation reveals coordinated microbiome, metabolic, and immune signaling changes accompanying tumor suppression
doi: 10.1080/19490976.2026.2690687iScience 29 (5), 115706
Genomic and phenotypic comparisons reveal lineage-specific traits of the probiotic Saccharomyces boulardii
doi: 10.1016/j.isci.2026.115706
2025
Nature Communications 16 (1), 663
Metagenome-guided culturomics for the targeted enrichment of gut microbes
doi: 10.1038/s41467-024-55668-yEMBO Reports 26 (7), 1688–1708
Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite
doi: 10.1038/s44319-025-00386-9Journal of Agricultural and Food Chemistry 73 (24), 15199–15214
Advanced Microbiome Therapeutics Accelerate MASLD Recovery by Restoring Intestinal Microbiota Equilibrium and the Gut-Liver Axis in a Mouse Model
doi: 10.1021/acs.jafc.5c01674
2024
2023
Scientific Reports 13 (1), 12506
Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
doi: 10.1038/s41598-023-39365-2Molecular Metabolism 78, 101823
Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model
doi: 10.1016/j.molmet.2023.101823
2022
ACS Synthetic Biology 11 (12), 4184-4192
Characterization of eight bacterial biosensors for microbial diagnostic and therapeutic applications
doi: 10.1021/acssynbio.2c00491